Lam Research (LRCX) Stock Faces Q1 Earnings Quality Questions After Records
π Lam Research posted record Q1 2027 revenue of US$8.22 billion and non-GAAP EPS of US$2.20, marking a substantial increase from the prior year.
π° The company achieved a historic operating margin of 40.2% and generated record free cash flow of US$3.24 billion in the quarter.
π€ Lam Research's Customer Support Business Group is running near US$2.5 billion per quarter, driven by upgrades and new AI-enabled offerings like Dextro cobot tools.
π Despite strong earnings, the stock price slipped slightly to around US$230, indicating markets may view the results as already priced in.
β οΈ Management has invested over US$3 billion into new R&D labs and a large Oregon AI semiconductor facility scheduled to open in 2028.
π Investors are concerned that delays in customer adoption or changes in device roadmaps could leave the expanded cost base underutilized.
π Analysts suggest Lam Research's current valuation might be overvalued by approximately 32% based on cash flow metrics alone.
- Lam Research achieved record Q1 2027 revenue of US$8.22 billion and non-GAAP EPS of US$2.20, significantly outpacing analyst expectations.
- The company hit a new operating margin high of 40.2% and generated record free cash flow of US$3.24 billion in the quarter.
- The Customer Support Business Group is tracking above 30% growth in 2026, with management projecting over 15% growth for 2027.
- Lam Research is successfully tilting its business mix toward higher-margin NAND conversions, advanced packaging, and services.
- The stock price barely reacted to record earnings, slipping slightly to around US$230, suggesting the market views the results as already priced in.
- Analysts estimate Lam Research could be overvalued by approximately 32% when looking at cash flow generation versus income statement metrics.
- The company has poured more than US$3 billion into new R&D labs and a large Oregon facility, creating risk if customer adoption of new tool platforms is delayed.